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Nucleolin is a prominent nucleolar protein that is mobilized into the cytoplasm during infection by
enteropathogenic Escherichia coli (EPEC). Nucleolin also exists at low levels at the cell surface of
eukaryotic cells and here we show that upon infection of an intestinal cell model, EPEC recruits
and subsequently sequesters cell-surface EGFP-nucleolin into extracellularly located bacterial
microcolonies. The recruitment of nucleolin was evident around bacteria within the centre of the
microcolonies that were not directly associated with actin-based pedestals. Incubation of host
intestinal cells with different ligands that specifically bind nucleolin impaired the ability of EPEC to
disrupt epithelial barrier function but did not inhibit bacterial attachment or other effector-driven
processes such as pedestal formation or microvilli effacement. Taken together, this work suggests
that EPEC exploits two spatially distinct pools of nucleolin during the infection process.
INTRODUCTION
Enteropathogenic Escherichia coli (EPEC) is a non-invasive
pathogen that binds to human small intestinal enterocytes
and delivers multiple effector proteins into host cells via its
type III secretion system (Dean & Kenny, 2009). These
effectors subvert many aspects of host cell physiology,
ultimately leading to diarrhoeal disease (Dean & Kenny,
2009). EPEC poses a significant threat in developing
countries and is a leading cause of infantile diarrhoea
(Chen & Frankel, 2005). Although the functions of EPEC
effectors are becoming determined, the interaction of
EPEC with the host plasma membrane is less clear. EPEC
does not typically enter host intestinal cells but forms three
dimensional microcolonies on the host cell surface
mediated by the bundle-forming pilus (Nougayre `de et al.,
2003). As physical contact between the bacterium and the
host cell membrane is required for the delivery of the
effectors, it follows that many individual bacteria within
the attached microcolony will not be engaged in the
delivery of effectors.
EPEC belongs to a family of pathogens that include
enterohaemorrhagic E. coli (EHEC) and Citrobacter roden-
tium. These pathogens all share the LEE (locus of enterocyte
effacement) genomic pathogenicity island, which encodes
several important virulence factors including the type III
secretion system, six effectors and the outer-membrane
protein intimin. The effector Tir (translocated intimin
receptor) is the best-studied LEE effector; it inserts into the
host plasma membrane, where it acts as a receptor for
intimin and facilitates bacterial attachment (Kenny et al.,
1997). Upon binding intimin, Tir induces extensive actin
polymerization within the host cell, leading to the formation
of an actin-rich pedestal (Kenny et al., 1997).
Recently, another LEE effector, EspF, was shown to cause
extensive mobilization of the nucleolar protein nucleolin
from the nucleolus into the cytoplasm during late-stage
infection (Dean et al., 2010; Holmes et al., 2010). Nucleolin
is the most abundant protein in the nucleolus, where it plays
important roles in ribosome biogenesis, although several
studies have also demonstrated the presence of nucleolin at
the cell surface by antibody detection (Christian et al., 2003;
Hovanessian et al., 2000; Losfeld et al., 2009; Nisole et al.,
1999; Storck et al., 2007; Watanabe et al., 2010). However,
given that nucleolin-like proteins have also been detected at
the cell surface (de Verdugo et al., 1995; Kleinman et al.,
1991; Krantz et al., 1995), concerns have been raised
regarding the use of antibodies to detect cell-surface
nucleolin (Ginisty et al., 1999). Immunodetection was used
to demonstrate that cell-surface nucleolin is recruited in vivo
by EHEC to the vicinity of the bacterial attachment site
(Sinclair et al., 2006), where it is believed to act as a bacterial
adhesin (Sinclair & O’Brien, 2002). Indeed, nucleolin has
been shown to directly bind the EPEC and EHEC outer-
membrane protein intimin (Sinclair & O’Brien, 2002)
although the relevance of this during infection of host cells
is less clear as intimin was not shown to colocalize with
nucleolin during EPEC/EHEC infection of Hep-2 cells
(Sinclair & O’Brien, 2004). Thus, the nature of nucleolin
recruitment by EHEC and the importance of this during
EPEC infection remain to be determined.
Abbreviations: DAPI, 49-6-diamidino-2-phenylindole; EGFP, enhanced
green fluorescent protein; EHEC, enterohaemorrhagic E. coli; EPEC,
enteropathogenic E. coli; IF, immunofluorescence; MK, midkine; PTN,
pleiotrophin; SEM, scanning electron microscopy; TER, transepithelial
resistance; TRITC, tetramethylrhodamine isothiocyanate.
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recruitment during EPEC infection of intestinal cells by
expressing enhanced green fluorescent protein (EGFP)-
nucleolin in the small intestinal Caco-2 model. We reveal
that nucleolin is not only recruited to the EPEC infection
site but is also sequestered transiently inside extracellularly
located bacterial microcolonies. We present data to
suggest that cell-surface nucleolin is involved in the
EPEC infection process but does not significantly
contribute to bacterial attachment or effector delivery.
Taken together, the work shows that EPEC exploits two
spatially distinct pools of nucleolin: the main nucleolar
pool during late-stage infection and a cell-surface pool at
earlier infection times.
METHODS
Cell line, plasmid and bacterial strain. Caco-2 cells were cultured
and transiently transfected with pEGFP-nucleolin as described
previously (Dean et al., 2010). Infection experiments were performed
with the prototypical EPEC strain E2348/69. This strain carries the
EAF plasmid, which enables the bacteria to form compact micro-
colonies on infected host cells.
Confocal microscopy. For microscopy, all transfected cells
(5–7 days post-seeding) were infected with EPEC E2348/69 at an
m.o.i. of 1:50 using standard infection procedures (Dean & Kenny,
2004) and processed for confocal microscopy as described previously
(Dean et al., 2010). Cells were stained for filamentous actin (TRITC-
phalloidin) and DNA (DAPI) and viewed on a Leica SP2 confocal
microscope. Pedestal formation (the polymerization of actin
underneath the bacteria) is a diagnostic indicator of EPEC infection
and was used, along with DAPI, to identify EPEC infection sites.
Image deconvolution was performed with Huygens professional
deconvolution software. Immunofluorescence was performed using
the nucleolin antibody MS-3 (Santa Cruz Biotechnology) as
described by Sinclair & O’Brien (2004) or ab22758 (Abcam) as
described by Dean et al. (2010). Caco-2 cells were processed in a
variety of ways to try to visualize cell-surface nucleolin by
immunofluorescence, including fixation with 2–4% paraformaldeh-
dye or methanol, permeabilization using 0.1% Tween 20, 0.2%
Triton X-100 or 0.1% saponin, or not permeabilized at all. In all
cases, and despite a strong nuclear signal of nucleolin, cell-surface
nucleolin was not detected by immunofluorescence on these cell
types (not shown).
Nucleolin ligand-binding assays. Differentiated Caco-2 cells
(15 days post-confluence) were exposed to different concentrations
of midkine or pleiotrophin (R and D systems) for 3 h prior to
infection with wild-type EPEC as described by Dean & Kenny
(2004). Procedures relating to transepithelial resistance (TER) and
scanning electron microscopy have been described previously (Dean
& Kenny, 2004; Dean et al., 2006). Confocal microscopy was used to
determine the number of attached bacteria following three washes
in PBS and DAPI staining. Pedestal formation was assessed by
fluorescent actin staining using phalloidin as described by Dean &
Kenny (2004). Neither midkine nor pleiotrophin had any observ-
able effects on the appearance of host cells or on TER values (not
shown).
Statistical analyses. Means were compared by ANOVA or
Student’s t-test using the statistical package SPSS, with P-values
below 0.01 taken as significant.
RESULTS
EPEC transiently recruits cell-surface nucleolin
during infection of intestinal cells
Previous studies have shown that EHEC recruits cell-
surface nucleolin to the vicinity of the bacterial infection
site on cell lines (Sinclair & O’Brien, 2004) and during in
vivo infection (Sinclair et al., 2006). However, although
nucleolin has been shown to bind directly to the EHEC
outer-membrane protein intimin, it was not found to
colocalize with the bacterial outer membrane during EPEC/
EHEC infection of host cells (Sinclair & O’Brien, 2004) and
thus the role of nucleolin and the nature of nucleolin
recruitment during infection remain undetermined.
Recently, we have shown that nucleolin within the host-cell
nucleus is significantly disrupted following prolonged
EPEC infection (Dean et al., 2010) and this analysis was
extended to assess nucleolin’s behaviour at the cell surface
of intestinal cells. Using two different nucleolin antibodies
(see Methods) that have been used previously to detect
both nuclear (Dean et al., 2010) and cell-surface nucleolin
on Hep-2 cells (Sinclair & O’Brien, 2004), we were unable
to detect cell-surface nucleolin on intestinal Caco-2 cells
despite observing nucleolar nucleolin with these antibodies
(Fig. 1a). Indeed, a range of fixation and permeabilization
methods were employed (see Methods) in an attempt to
detect cell-surface nucleolin by immunofluorescence (IF)
but these were unsuccessful (data not shown), suggesting
that the expression of native nucleolin on the surface of
Caco-2 cells may be below detection levels by IF, despite
being detected in cell fractions of Caco-2 cells by Western
blot analysis (Dean et al., 2010). This low level of nucleolin
expression at the cell surface is in line with previous in vivo
findings using mouse, calf and piglet intestinal sections
(Sinclair et al., 2006). Thus, because of the weak IF signal
with intestinal Caco-2 cells, we employed an overexpres-
sion system using an EGFP-nucleolin fusion expressed in
the Caco-2 cell line to follow the behaviour of cell surface
nucleolin during EPEC infection.
Confocal analysis of Caco-2cells (5–7 days differentiated)
that were transiently transfected with EGFP-nucleolin
revealed that in agreement with the IF data (Fig. 1a),
nucleolin was only detected in the nucleolus/nucleus of
uninfected cells, with no observable accumulation at the
cell surface – consistent with previous reports on other cell
types (Chen & Huang, 2001; Dean et al., 2010). This
nucleolar/nuclear localization pattern of EGFP-nucleolin
remained unaltered following a 30 min infection with
EPEC (Fig. 1b) but by 60–120 min, it strongly colocalized
with the EPEC microcolonies on the surface of transfected
Caco-2 cells (Fig. 1c). Although recruitment of cell-surface
EGFP-nucleolin was a prominent event, not all bacterial
microcolonies were engaged in recruiting EGFP-nucleolin
(~50%; Fig. 1e). By 180 min post-infection, cell-surface
EGFP-nucleolin associated with attached bacteria (detected
by DAPI and actin pedestals) had diminished to near
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recruitment was a transient event. This loss of recruited
EGFP-nucleolin coincided with the mobilization of
nucleolin into the cytoplasm (Fig. 1d) and the loss of
nucleolin from the membrane fraction of Caco-2 cells, as
reported previously (Dean et al., 2010). These microscopy
Fig. 1. EPEC recruits EGFP-nucleolin at the cell surface. (a) Immunofluorescence of confluent Caco-2 cells stained for
nucleolin and visualized along the x–y (aerial view) or x–z axis (cross-section). (b–d) Caco-2 cells (5–7 days post-confluence)
expressing EGFP-nucleolin infected with EPEC for (b) 30 min, (c) 60–120 min and (d) 180 min. Arrows in (b) and (d) indicate
bacterial-associated actin pedestals. The square in (c) indicates microcolony-associated EGFP-nucleolin. Yellow scale bars,
5 mm. Bacteria appear blue in all images. (e) Percentage of bacterial microcolonies assocated with EGFP-nucleolin signal at
different infection times. Microcolonies were counted only on host cells expressing EGFP-nucleolin, and a region of interest
around each microcolony was made and assessed for the EGFP levels above the background signal. Bars show mean±SEM
(n53). (f) Quantification of the subcellular EGFP-nucleolin signal. The nucleolin fluorescence signal was quantified using
confocal software. Regions of interest were detected as follows: the host nucleus was determined using DAPI; the cytoplasm
was the region between the host nucleus and the cell peripheral actin stain; microcolonies were located using the bacterial
DAPI stain. The nucleolin signal in different fractions is expressed as a percentage of total cell fluorescence. Values are
means±SEM (n53).
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associated EGFP-nucleolin (Fig. 1e) and subcellular location
of the EGFP-nucleolin signal during infection (Fig. 1f),
which provided further evidence that nucleolin recruitment
was a transient event. Cell surface nucleolin was found to be
intimately associated with EPEC microcolonies (see below),
but it was unclear whether the transience of cell-surface
recruitmentwasrelatedtochangesinmicrocolonydynamics
during the infection process.
As EPEC infection caused highly localized recruitment of
EGFP-nucleolin at the cell surface, we tested whether native
nucleolin could be visualized at the cell surface of infected
cells by IF of infected cells. A small increase in native cell-
surface nucleolin signal was detected that colocalized with
attached microcolonies but the staining was weak and
diffuse (data not shown). Because of this, we continued to
use EGFP-nucleolin to study nucleolin’s behaviour during
EPEC infection.
EPEC sequesters nucleolin inside bacterial
microcolonies
To gain further insight into the nature of the cell-surface
nucleolin recruitment, we performed high-magnification
confocal analysis along the z-axis of infected cells.
Remarkably, confocal sectioning through attached bacterial
microcolonies revealed that the recruited EGFP-nucleolin
was found, not beneath the bacteria, but throughout the
microcolony, sequestered around individual bacteria
(Fig. 2a). Incremental 0.8 mm z-axis sections (Fig. 2b)
showed EGFP-nucleolin in each cross-section of the
microcolony, even up to 4 mm above the level of the host
cell plasma membrane, near the microcolony apex
(Fig. 2b). Infection of Caco-2 cells expressing EGFP alone
did not result in EGFP sequestration by the bacterial
microcolonies, suggesting that the findings were specific to
the recruitment of nucleolin (data not shown). A previous
IF study using Hep-2 cells infected with EPEC (Sinclair &
O’Brien, 2004) did not report that nucleolin was
sequestered inside bacterial microcolonies, suggesting that
this may not occur on non-target Hep-2 cells or that the
levels of nucleolin within the microcolonies were too low
to detect by IF.
The nucleolin ligands midkine and pleiotrophin
inhibit EPEC-mediated disruption of barrier
function
To test the involvement of cell-surface nucleolin in EPEC
infection, we used the cytokine midkine (MK) and the
growth factor pleiotrophin (PTN), which bind cell-surface
nucleolin (Said et al., 2005; Take et al., 1994) and inhibit
HIV attachment to host cells (Hovanessian, 2006). We
assessed whether MK or PTM exposure to Caco-2 cells
would interfere with various aspects of the EPEC infection
process including (i) disruption of transepithelial electrical
resistance (TER; a measure of epithelial barrier function),
(ii) microvilli effacement, (iii) pedestal formation and (iv)
Fig. 2. EPEC sequesters EGFP-nucleolin into its microcolonies. (a) High-resolution image showing bacterial microcolony
associated with extensive EGFP-nucleolin at 120 min post-infection. (b) The bacterial microcolony in (a) was sectioned at
0.8 mm increments along the z axis and the images were deconvolved to reveal the EGFP-nucleolin pattern within the
microcolony. Yellow scale bars, 3 mm.
P. Dean and B. Kenny
1764 Microbiology 157bacterial attachment. In agreement with previous studies
(Dean & Kenny, 2004), EPEC caused a rapid loss of TER on
Caco-2 cells (Fig. 3a) that was significantly attenuated on
cells that had been incubated for 3 h with MK (Fig. 3a) or
PTN (Fig. 3b) in a dose-dependent manner (P,0.001).
Further analysis using MK revealed no significant defects in
the ability of EPEC to attach to host cells (Fig. 4a, P50.875;
and Fig. 4c), induce actin-based pedestals (Fig. 4b; P50.584)
or cause microvilli effacement (Fig. 4c) at the same
MK concentrations as used in the TER experiments.
Importantly, microvilli effacement is mediated by at least
three EPEC effector proteins that are delivered into the host
cell (Deanet al., 2006),while pedestal formation requiresthe
effector protein Tir, suggesting that MK does not disrupt
effector protein delivery. The results also show that MK had
noeffectontheability of EPEC toattachtointestinalCaco-2
cells, suggesting that either MK does not efficiently block
EPEC-nucleolin binding, or nucleolin may not act as an
adhesin for EPEC on Caco-2 cells, unlike that shown on
non-target Hep-2 cells with EHEC (Sinclair et al., 2006).
DISCUSSION
Nucleolin is a well-studied eukaryotic protein that is
important for ribosome biogenesis and represents the most
abundant nucleolar protein in dividing cells (Ginisty et al.,
1999). It is becoming increasingly clear that nucleolin
exhibits a plethora of extra-ribosomal functions, many of
which occur outside the nucleolus (Ginisty et al., 1999;
Srivastava & Pollard, 1999; Ugrinova et al., 2007). A number
of pathogens have been shown to target nucleolin or cause
changes in its subcellular location, an event which likely
alters the cellular function of this protein. EHEC has been
previously shown to recruit nucleolin to the vicinity of the
bacterial infection site in vivo (Sinclair et al., 2006). Given
the similar modes of pathogenesis of the two pathogens, it
was not surprising to find that EPEC recruited cell-surface
EGFP-nucleolin in Caco-2 cells. However, our finding that
nucleolin was transiently sequestered into the inside of
extracellular bacterial microcolonies was a novel and
unexpected finding. Moreover, all of the EGFP-nucleolin
recruited by EPEC was inside microcolonies, with no
detectable nucleolin beneath adherent bacteria that were
engaged with the host plasma membrane. Further work is
requiredtodeterminewhynucleolinrecruitmentistransient
and whether the bacteria actively degrade the nucleolin
within the microcolony during infection.
Cell-surface nucleolin was previously shown to be an
adhesin for EHEC but this may not be the case for EPEC
as (a) nucleolin was found inside EPEC microcolonies and
not at the interface between host cells and bacteria and (b)
MK or PTN had no significant effect on bacterial
attachment. Both MK and PTN were used at high
concentrations that have previous been shown to saturate
thenucleolin-bindingsitesonarangeofcelltypes(Saidetal.,
2002, 2005) and that also completely inhibit the nucleolin-
mediated attachment of HIV to host cells. Nevertheless, it is
still possible that MK may not specifically impede the
binding of EPEC cells to nucleolin, and this could explain
why this cytokine did not affect EPEC adherence levels.
The positive correlation between MK exposure and EPEC’s
inability to disrupt epithelial barrier function suggests that
nucleolin may play a role in this process, and indeed several
studies have shown that cell-surface nucleolin mediates
signalling pathways (Losfeld et al., 2009; Reyes-Reyes &
Akiyama, 2008) that may affect the integrity of the
epithelial barrier. We have not ruled out the possibility
that MK and PTN may have non-specific effects on the
host cell, unrelated to nucleolin, that may also impede
EPEC’s ability to reduce the TER without influencing type
III secretion or adhesion. Thus, further work is needed to
elucidate the involvement of nucleolin in this process and
how the bacteria subvert its function.
In this study, and in agreement with a recent report (Dean
et al., 2010), we show that EPEC causes the cytoplasmic
mobilization of EGFP-nucleolin from the nucleolus during
late-stage infection. The recruitment of cell-surface
nucleolin into bacterial microcolonies occurs earlier in
infection, prior to this dramatic event. Thus, taken
together, this work supports the notion that EPEC exploits
two distinct pools of nucleolin during the infection process
Fig. 3. Nucleolin ligands impair the loss of TER during EPEC
infection: TER of Caco-2 cells treated with or without (a) MK or (b)
PTN and then infected with EPEC for 4 h. All data points represent
means±SEM, n53. *, P,0.05; **, P,0.01.
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much later nucleolar/nuclear pool (Dean et al., 2010) –
which appear to have very different roles during the EPEC
infection process. Future work may shed light on whether
this versatile eukaryotic protein plays key roles in host–
pathogen interactions.
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